Article · 2017
Editorial Board Member
Anupam Bishayee
Associate Professor, American University of Health Sciences, USA
About
As published by the journal they serve.
Dr. Bishayee has 25 years combined experience in pharmaceutical education, research, teaching, and administration. Before joining American University of Health Sciences (Signal Hill, CA) as Founding Chair and Associate Professor of Pharmaceutical Sciences, Dr. Bishayee served as a charter faculty member in the Department of Pharmaceutical Sciences, College of Pharmacy and Research Assistant Professor in the Department of Internal Medicine, College of Medicine at the Northeast Ohio Medical University (Rootstown, OH). Dr. Bishayee’s research focuses on elucidation of the cancer preventive and therapeutic effects of medicinal plants, natural products, dietary and synthetic agents using various pre-clinical models of cancer. His laboratory is currently involved in examining chemopreventive and therapeutic potential of various dietary agents, including grape polyphenols (such as resveratrol), pomegranate phytoconstituents, berry anthocyanins and other natural products as well as various novel synthetic agents in breast and liver cancer. His research group is also assessing the possibility of targeting various cell signaling pathways, including nuclear factor E2-related factor 2, nuclear factor-kappaB, and Wnt/beta-catenin pathway, to achieve chemoprevention and therapy of several neoplastic diseases. The ongoing projects of Dr. Bishayee are funded by the National Cancer Institute/National Institutes of Health as well as private pharmaceutical/biotechnological institutions. Dr. Bishayee has published 95 original research papers and review articles in high-impact, peer-reviewed journals, such as Biochemical Pharmacology, Cancer Prevention Research, Carcinogenesis, Current Cancer Drug Targets, Cancer Letters, Pharmaceutical Research, and International Journal of Cancer, 10 book chapters, and presented over 25 papers at various national and international scientific meetings. Dr. Bishayee served as special theme-issue guest editor for the Current Pharmaceutical Biotechnology and Currant Cancer Drug Targets. Dr. Bishayee is the Associate Editor-in-Chief of World Journal of Gastroenterology and Associate Editor of BMC Complementary and Alternative Medicine. He is also currently serving as an editorial board member of several reputed journals, including Anti-Cancer Drugs, American Journal of Cancer Science, Chemoprevention, Journal of Carcinogenesis and Mutagenesis and World Journal of Hepatology, and ad-hoc reviewer of more than 40 peer-reviewed scientific journals, including Nature Reviews. Dr. Bishayee has received several research awards, including “Young Investigator” award (Indo-American Society of Nuclear Medicine and Dublin Institute of Technology, Ireland), “Younger Scientist” award (National Science Council, Canada and Indian Chemical Society), as well as “most cited”, “most accessed” and “high-impact” articles in Cancer Prevention Research, Molecular Nutrition and Food Research and World Journal of Hepatology, respectively. He is an active member of various organizations devoted to scientific research and pharmacy education.
Journals they serve
The seats these journals name them in.
- Biology and MedicineEditorial Board Member
Articles we hold
Articles in the journals they serve whose byline carries this name.
Article · 2017
Natural product-based cancer prevention and intervention: From ethnopharmacology to modern medicine
Article · 2015
Chemoprevention of experimental mammary carcinoma by Trianthema portulacastrum Linn., an Indian dietary and medicinal plant
Article · 2014
Breast cancer prevention and treatment with oleanane triterpenoids
Article · 2013
Cancer prevention and treatment by natural products: Current evidence and future opportunities
Article · 2010
Angioprevention is Implicated in Resveratrol Chemoprevention of Experimental Hepatocarcinogenesis
This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.
